Cargando…
Performance Characteristics of the BluePrint® Breast Cancer Diagnostic Test()
The analytical performance of a multi-gene diagnostic signature depends on many parameters, including precision, repeatability, reproducibility and intra-tumor heterogeneity. Here we study the analytical performance of the BluePrint 80-gene breast cancer molecular subtyping test through determinatio...
Autores principales: | Mittempergher, Lorenza, Delahaye, Leonie JMJ, Witteveen, Anke T, Snel, Mireille HJ, Mee, Sammy, Chan, Bob Y, Dreezen, Christa, Besseling, Naomi, Luiten, Ernest JT |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Neoplasia Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7097521/ https://www.ncbi.nlm.nih.gov/pubmed/32208353 http://dx.doi.org/10.1016/j.tranon.2020.100756 |
Ejemplares similares
-
Decentralization of Next-Generation RNA Sequencing-Based MammaPrint® and BluePrint® Kit at University Hospitals Leuven and Curie Institute Paris
por: Slembrouck, Laurence, et al.
Publicado: (2019) -
Equivalence of MammaPrint array types in clinical trials and diagnostics
por: Beumer, Inès, et al.
Publicado: (2016) -
A breast cancer gene signature for indolent disease
por: Delahaye, Leonie J. M. J., et al.
Publicado: (2017) -
MammaPrint and BluePrint comprehensively capture the cancer hallmarks in early‐stage breast cancer patients
por: Haan, Josien C., et al.
Publicado: (2021) -
BluePrint breast cancer molecular subtyping recognizes single and dual subtype tumors with implications for therapeutic guidance
por: Kuilman, Midas M., et al.
Publicado: (2022)